--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "DrDrugs: Guide for Physicians" developer_entity: "Skyscape Medpresso Inc" bundle_id: "com.medpresso.Lonestar.drdrug" app_store_id: "1249280046" category: "Medical" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2026-06-17" report_date: "2026-08-25" last_verified: "2026-08-25T00:00:00.000Z" report_version: "5.9.2" total_reviews: 33 overall_rating: 4.5 confidence: "low" confidence_score: 0.3 data_age_days: 37 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "subscription", "mobile app", "app review", "app analysis", "medical", "students,", "residents,"] canonical_url: "https://marlvel.ai/apps/drdrugs-guide-for-physicians" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # DrDrugs: Guide for Physicians Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Subscription - **Signal**: Rating 4.45 > **TL;DR:** DrDrugs: Guide for Physicians is a medical app by Skyscape Medpresso Inc, rated 4.45/5 by 33 users, available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** DrDrugs: Guide for Physicians is a medical app by Skyscape Medpresso Inc. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.45/5 (33 reviews) | | **Category** | Medical | | **Developer** | Skyscape Medpresso Inc | | **Pricing** | Subscription | | **Platforms** | iOS | | **Confidence** | Low (0.3/1.0) | | **Data Age** | 37d | ## Metadata & Market Performance - **Publisher:** Skyscape Medpresso Inc - **Category:** Medical - **Target Audience:** Medical students, residents, and practicing physicians. - **Platforms:** iOS - **Version Reviewed:** 5.9.2 - **Report Date:** 2026-08-25 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.3/1.0) - **App Store ID (iOS):** 1249280046 - **Bundle ID:** com.medpresso.Lonestar.drdrug - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-08-25 ## Executive Snapshot **What it is:** DrDrugs: Guide for Physicians is a clinical reference app for medical students and physicians, featuring drug monographs and integrated dosing tools on iOS. **Why users hire it:** The app replaces manual cross-referencing of drug safety data and dosing calculations with a single-workflow interface, reducing the risk of administration errors in high-stakes clinical environments. ## App DNA (Features & Intent) - **[Standard] Drug Monographs:** Access to 1,400+ drug monographs with clinical prescribing and monitoring data. - **[Differentiator] Integrated Dosing Calculators:** 700+ weight-based dosing tools allow calculation and administration within a single workflow. - **[Differentiator] Patient Safety Markers:** High-alert medication markers and REMS icons highlight life-threatening side effects. * *User Intent:* Users want timely prompts to stay engaged without missing updates. ## Market Position {#market-position} DrDrugs maintains a 4.45-star rating across 33 reviews, reflecting a stable but niche user base. The recent drop to #84 Grossing in the category suggests that the current subscription pricing may be facing resistance against more accessible clinical references. ## Monetization Strategy - **Model:** Subscription - **Tiers:** Free trial with sample content, Yearly auto-renewing subscription at $38.99 - **Analysis:** The $38.99 annual subscription gates full clinical content, positioning the app as a professional-grade tool rather than a casual resource. ## SWOT Analysis {#swot} **Core Strengths:** - Integrated dosing calculators enable single-workflow administration - High-alert medication markers support clinical safety protocols **Growth Levers:** - Expanding pediatric dosing tools for residency training ## Recent Changes (v2 → v3) {#recent-changes} The app has shifted from a stable maintenance posture to a defensive stance, marked by a drop in grossing rank and a formal acknowledgment that its $38.99 price point is alienating the medical student segment. **Overall trend**: Declining **Compared at**: 2026-08-25 ### High-impact changes - **[Declined] Grossing Rank Decline** (positioning) ### Medium-impact changes - **[Shifted] Competitive Threat Refinement** (swot) - **[Shifted] Pricing Barrier Acknowledgment** (pricing) ## What's New - **Latest (v5.9.2, 2 months ago):** Updated to 20th Edition with new drug monographs, high-alert medication lists, and current REMS safety information. ## App Momentum (Maintenance) {#momentum} - Ships one update every 69 days. - Updated 2026 drug monographs and guidelines. > **Cadence:** 1 total versions · 1 majors in last 6 months · 69 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} DrDrugs: Guide for Physicians is a medical app. It holds a 4.45/5 rating from 33 reviews. > **Bottom Line:** DrDrugs relies on its specialized safety-marker integration to justify a premium subscription, but the lack of a student-accessible tier limits its growth potential. Adjusting the pricing strategy to capture medical students would unlock a larger user base and improve market penetration. **Best for:** Medical students, residents, and practicing physicians. ### PM Action Plan (Next Best Moves) - [ ] [PIVOT] Introduce a tiered student subscription because the $38.99 annual price point is a barrier to entry for medical students → increase top-of-funnel conversion ### Outlook: Stable The clinical reference market is shifting toward institutional-access models, leaving individual-subscription tools like DrDrugs exposed to price-sensitive users. Maintaining the current high-cost, low-cadence model will likely result in stagnant growth as more accessible, frequently updated rivals gain traction. - ⚪ The 69-day update cadence indicates a maintenance-focused development cycle that prioritizes content accuracy over rapid feature expansion. - 🔴 Downward rank movement in European markets suggests the current subscription model faces stiff competition from lower-cost regional alternatives. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.45/5 | | Total Reviews | 33 | | Confidence | Low | | Pricing Model | Subscription | | Platforms | iOS | | Key Features | 3 analyzed | | Trend | Declining | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **DrDrugs: Guide for Physicians** (this app) | 4.45/5 | N/A | Skyscape Medpresso Inc | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Skyscape Medpresso Inc - **Website:** [https://www.skyscape.com/product/DrDrugs-Drug-Guide-for-Physicians](https://www.skyscape.com/product/DrDrugs-Drug-Guide-for-Physicians) - **Social:** [Instagram](https://instagram.com/skyscapeinc) · [Facebook](https://www.facebook.com/skyscapeinc) · [X/Twitter](https://twitter.com/skyscapeinc) · [YouTube](https://www.youtube.com/watch) · [LinkedIn](https://www.linkedin.com/in/sandeep131) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/drdrugs-guide-for-physicians/id1249280046?uo=4) - **Dev Site:** [Official Website](https://www.skyscape.com/product/DrDrugs-Drug-Guide-for-Physicians) - **Sources:** Developer website content, About us / company information, App store metadata. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*1O Patient Portal*](https://marlvel.ai/apps/1o-patient-portal) (1st Optimal, LLC) · N/A Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.3/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 37 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/drdrugs-guide-for-physicians) Data licensed for AI Agent attribution under CC-BY-NC 4.0.